GAMMA Investing’s MacroGenics MGNX Stock Holding History

GAMMA Investing’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.51K	Buy	+909	New	+$3.75K	﹤0.01%	3784
2024 Q4	–	Sell	-190	Closed	-$625	–	3810
2024 Q3	$625	Sell	190 -1,039	-85%	-$4.05K	﹤0.01%	3358
2024 Q2	$5.22K	Sell	1,229 -444	-27%	-$4.32K	﹤0.01%	2559
2024 Q1	$24.6K	Buy	1,673 +64	+4%	+$967	0.01%	1496
2023 Q4	$23K	Buy	+1,609	New	+$11.1K	0.01%	1399

Other funds holding MGNX

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's MGNX Position: Q3 2026 in Review

GAMMA Investing opened a new position in MacroGenics (MGNX) in Q3 2026: 909 shares worth $3.51K. The stake represents ﹤0.01% of the portfolio and ranks #3784 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in MGNX as recently as Q3 2024.

GAMMA Investing first reported a position in MGNX in Q4 2023 and has held it in 5 quarters since. The position peaked at $24.6K in Q1 2024. 3 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

GAMMA Investing held 909 shares of MacroGenics worth $3.51K as of Q3 2026.
MacroGenics was a new GAMMA Investing position in Q3 2026.
MacroGenics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3784 holding.
GAMMA Investing first reported a position in MacroGenics in Q4 2023 and has held it in 5 quarters since.
GAMMA Investing's MacroGenics position peaked at $24.6K in Q1 2024.
3 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.